[SAGE] Erenumab and Galcanezumab for Chronic Migraine Refractory to OnabotulinumtoxinA: A Real-World Comparative Study |
|
This post will be closed automatically in 2026-06-19 20:05
Reward50points
|
10
Patient-reported outcome measures and their association to the original Strickland classification after flexor tendon repair
10
Neuroqueering the Psychoanalytic Lens
10
Digital Economy and Regional Tourism Development: The Mediating Role of Information Search from a Spatial Spillover Perspective
50
Erenumab and Galcanezumab for Chronic Migraine Refractory to OnabotulinumtoxinA: A Real-World Comparative Study
20
Article: Differences in Impulse Oscillometry Parameters Measured Using Different Devices
